Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNX Defiance Daily Target 2X Long MRNA ETF

交易中 05-28 14:15:34 EDT

20.62

-0.82

-3.82%

最高20.70	最低19.95	成交量1.30万
今开20.50	昨收21.43	日振幅3.50%
总市值226.77万	流通市值226.77万	总股本11.00万
成交额26.44万	换手率11.82%	流通股本11.00万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNX","market":"US","secType":"STK","nameCN":"Defiance Daily Target 2X Long MRNA ETF","latestPrice":20.615,"timestamp":1779991581860,"preClose":21.4342,"halted":0,"volume":12999,"delay":0,"changeRate":-0.03821929439867138,"floatShares":110000,"shares":110000,"eps":0,"marketStatus":"交易中","change":-0.8192,"latestTime":"05-28 14:15:34 EDT","open":20.5,"high":20.7,"low":19.95,"amount":264377.82168,"amplitude":0.034991,"askPrice":21.17,"askSize":100,"bidPrice":20.14,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1779998400000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":21.4342,"sharesOutstanding":30000,"nav":20.92,"aum":2301200,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":21.13,"preClose":21.4342,"latestTime":"04:01 EDT","volume":1,"amount":21.13,"timestamp":1779955264161,"change":-0.3042,"changeRate":-0.014192,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":21.47,"preClose":21.4342,"latestTime":"19:59 EDT","volume":170,"amount":3682.3368,"timestamp":1779926363711,"change":0.0358,"changeRate":0.00167,"amplitude":0},"volumeRatio":0.783113},"requestUrl":"/m/hq/s/MRNX/tweets","defaultTab":"tweets","newsList":[{"id":"1158347106","title":"Moderna公司计划于八月中旬前备妥2026-27年度推荐新冠疫苗组分供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1158347106","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158347106?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:19","pubTimestamp":1779970758,"startTime":"0","endTime":"0","summary":"根据最新简报文件披露，Moderna公司已做好充分准备，预计将在八月中旬之前完成针对2026-27年度推荐新冠疫苗组分的生产供应部署。这一时间节点对于确保秋季疫苗接种计划的顺利推进具有关键意义，显示出该公司在应对公共卫生需求方面的前瞻性布局能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","MRNA","BK4501","BK4533","BK4548","BK4568","MRNY","BK4551","BK4532","BK4534","BK4139","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143160264","title":"个股聚焦：Moderna、英特尔、MidCap Financial Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=1143160264","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143160264?lang=zh_cn&edition=full","pubTime":"2026-05-11 17:46","pubTimestamp":1778492797,"startTime":"0","endTime":"0","summary":"Moderna  股价在盘前交易中飙升了8%。此前，这家生物医药公司向媒体透露，早在近期一艘邮轮爆发疫情之前，他们就已经启动了针对汉坦病毒的疫苗研发工作。市场对人工智能相关企业的热情持续高涨，推动这两家芯片制造商的股价双双上扬。就在上周五，它们的收盘价均创下了历史新高。据消息，阿波罗全球管理  已就出售其上市业务发展公司 MidCap Financial Investment Corp  进行了谈判。福克斯-A  则是今日计划公布财报的公司之一。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c3eded8fb3ee9cd51304c05def1e555f","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889566641.SGD","MULL","LINT","BK4585","IE00B19Z3B42.SGD","LU0097036916.USD","LU0203347892.USD","BK4125","LU2211815571.USD","IE0002270589.USD","LU2286300806.USD","IE00B19Z3581.USD","LU2089985449.USD","IE00B7SZLL34.SGD","BK4534","BK4501","MRNA","LU2543165471.USD","INTC","GB00BDT5M118.USD","APO","MRNY","BK4554","BK4602","LU0274383776.USD","04335","BK4579","BK4612","BK4529","BK4553","LU2360106780.USD","LU1316542783.SGD","LU0642271901.SGD","IE0009356076.USD","LU0792757196.USD","BK4551","MRNX","BK4535","LU1852331112.SGD","BK4543","BK4515","BK4588","FOXA","LU0127658192.USD","BK4141","BK4527","LU0203345920.USD","LU2458330169.SGD","BK4532","LU2048586759.USD","MU","LU0154236417.USD","LU0056508442.USD","LU1803068979.SGD","LU1267930813.SGD","LU0321505868.SGD","LU2931357623.SGD","INTW","BK4550","LU0321505439.SGD","LU0157215616.USD","LU0719512351.SGD","LU2148611432.USD","LU0109392836.USD","LU2250418816.HKD","IE000M9KFDE8.USD","IE00B5949003.HKD","LU2054465674.USD","BK4512","LU2458330243.SGD","LU1323610961.USD","BK4139","MFIC","BK4566","MUD","BK4533","BK4135","BK4575","LU0889565833.HKD","MUU","BK4548","BK4568","BK4605","LU1366333091.USD","LU0081259029.USD","LU0082616367.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144457907","title":"Moderna股价大涨逾10%，此前其公布mRNA汉坦病毒疫苗一期临床积极数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1144457907","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144457907?lang=zh_cn&edition=full","pubTime":"2026-05-08 23:14","pubTimestamp":1778253284,"startTime":"0","endTime":"0","summary":"Moderna周五早盘股价上涨超10%，此前公司公布了其mRNA汉坦病毒疫苗的一期临床积极数据。这一进展重新提振了投资者对Moderna mRNA产品管线的信心。对于Moderna而言，这项数据验证了其mRNA平台应对多种病毒疾病的能力。汉坦病毒一期数据及其对Moderna mRNA平台的意义Moderna针对其研究性汉坦病毒疫苗候选产品开展的一期临床研究显示，该疫苗耐受性良好，未出现严重安全性信号，并在所有剂量组中均诱导出强劲的抗体反应。","market":"us","thumbnail":"https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7c550214a914aa5b0d6e74a203b21919","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Moderna公布mRNA汉坦病毒疫苗一期临床积极数据","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","MRNX","MRNY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2633459715","title":"中慧生物-B(02627)：中国药审中心批准MRNA RSV疫苗IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2633459715","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633459715?lang=zh_cn&edition=full","pubTime":"2026-05-08 20:57","pubTimestamp":1778245029,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，继集团于2025年11月7日获美利坚合众国食品药品监督管理局批准其于美国提交的新药临床试验申请后，国家药品监督管理局药品审评中心已批准集团自主研发的mRNA RSV疫苗候选产品的IND申请。目前在中国，RSV感染的治疗仍依赖广谱抗病毒药物及对症治疗。因此，迫切需要开发一种有效的RSV疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439772.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4501","159646","BK4533","BK4585","BK4588","MRNX","BK4534","02627","MRNA","BK4548","BK4551","BK4568","IND","MRNY","BK4139","BK1161","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167020721","title":"Moderna 的 mRNA 流感疫苗在后期试验中表现优于标准疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1167020721","media":"老虎资讯综合","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167020721?lang=zh_cn&edition=full","pubTime":"2026-05-07 20:46","pubTimestamp":1778157971,"startTime":"0","endTime":"0","summary":"如果获批，Moderna 的疫苗将成为美国首款采用 mRNA 技术制成的季节性流感疫苗。研究人员表示，两组之间严重副作用发生率基本相当：接种 mRNA 疫苗的人群中为 2.2%，而接种标准剂量疫苗的人群中为 1.9%。今年 2 月，FDA 曾拒绝 Moderna 的申请，原因是对照组所使用的标准剂量流感疫苗存在争议。目前，Moderna 的流感疫苗也正在欧盟、加拿大和澳大利亚接受监管审查。","market":"us","thumbnail":"https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/fad861c5b82ebcd2a29c6ff47f3e0a8b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9f673a7486b2730831727fea6d8ee170","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Moderna 的 mRNA 流感疫苗在后期试验中表现优于标准疫苗","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","MRNA","MRNX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1150823990","title":"Moderna高管称公司正等待FDA指导 以恢复流感-新冠联合疫苗美国申报流程","url":"https://stock-news.laohu8.com/highlight/detail?id=1150823990","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150823990?lang=zh_cn&edition=full","pubTime":"2026-05-01 20:24","pubTimestamp":1777638268,"startTime":"0","endTime":"0","summary":"Moderna公司高管近日表示，该公司正在等待美国食品药品监督管理局的进一步指导，以确定恢复流感与新冠联合疫苗在美国申报的后续步骤。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4551","BK4548","MRNX","BK4588","MRNA","BK4568","BK4501","MRNY","BK4533","BK4139","BK4534","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104357139","title":"Moderna公布第一季度每股亏损3.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1104357139","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104357139?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:54","pubTimestamp":1777632878,"startTime":"0","endTime":"0","summary":"Moderna公司最新财报显示，第一季度营收达到3.89亿美元，远超华尔街分析师预期的2.28亿美元。尽管营收表现亮眼，公司当季每股亏损为3.40美元，略好于市场预估的每股亏损3.96美元。展望未来，Moderna预计将在2026年恢复销售增长态势，并有望获得包括季节性流感疫苗在内的多项新批准。财务储备方面，Moderna预计到2026年底，现金及投资规模将保持在45亿至50亿美元区间，为后续研发和市场拓展提供有力支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4534","BK4533","MRNA","BK4532","BK4588","BK4585","BK4501","BK4568","BK4548","MRNY","MRNX","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131327497","title":"Moderna预计2026年恢复销售增长 将获多项新批准含季节性流感疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1131327497","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131327497?lang=zh_cn&edition=full","pubTime":"2026-05-01 18:31","pubTimestamp":1777631481,"startTime":"0","endTime":"0","summary":"生物技术公司Moderna, Inc.近日宣布，公司预计将在2026年重返销售增长轨道。这一乐观预测基于其研发管线中多个候选药物即将获得的监管批准，其中包括备受关注的季节性流感疫苗。\nModerna管理层表示，除了流感疫苗外，公司还预期在2026年前获得其他几项重要产品的上市许可。这些新产品的陆续获批将为公司注入新的增长动力，帮助其扭转近期销售额下滑的局面。\n该公司强调，其在mRNA技术平台的持续投入正在进入收获期，未来将通过多元化产品组合推动业绩回升。市场分析师认为，若这些预期顺利实现，Moderna有望重新确立其在疫苗领域的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5c970505340e4afbf29108a4480b7217","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","BK4585","MRNA","BK4532","BK4548","MRNX","BK4533","BK4139","MRNY","BK4568","BK4588","BK4534","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137525165","title":"赛富时推出互联平台，整合多区域商业用户的数据、人工智能与客户互动","url":"https://stock-news.laohu8.com/highlight/detail?id=1137525165","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137525165?lang=zh_cn&edition=full","pubTime":"2026-04-28 21:08","pubTimestamp":1777381710,"startTime":"0","endTime":"0","summary":"赛富时宣布，其全新互联平台将实现跨多个地区的商业用户在数据管理、人工智能应用以及客户互动方面的无缝整合。该平台旨在通过统一的技术架构，帮助企业更高效地利用数据资源、部署智能算法，并优化客户参与流程，从而提升整体运营效能与市场响应速度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0310799852.SGD","LU1064131342.USD","LU1951200564.SGD","LU0234572021.USD","BK4550","LU1804176565.USD","LU0943347566.SGD","BK4567","LU2264538146.SGD","BK4581","LU1951198990.SGD","LU0082616367.USD","BK4613","LU0642271901.SGD","LU2357305700.SGD","LU0353189680.USD","BK4588","LU0820562030.AUD","LU0648001328.SGD","MRNY","LU0069063385.USD","LU0130102774.USD","LU0719512351.SGD","LU1988902786.USD","LU1496350502.SGD","LU1720051108.HKD","LU0689472784.USD","IE00B19Z8X17.USD","LU2244417387.USD","LU2361044865.SGD","LU2361044949.HKD","BK4535","LU2756315318.SGD","LU0157215616.USD","BK4607","BK4548","CRM","IE00BQXX3C00.GBP","LU1823568750.SGD","LU2458330243.SGD","LU0528227936.USD","LU1989764748.USD","BK4561","LU0211328371.USD","LU2265009873.SGD","LU0477156797.USD","LU0511384066.AUD","LU0127658192.USD","LU0289961442.SGD","BK4528","IE00BJTD4N35.SGD","LU0130103400.USD","LU1551013425.SGD","LU0354030511.USD","IE00BZ1G4Q59.USD","LU1201861165.SGD","LU1267930490.SGD","LU1267930813.SGD","LU0889566641.SGD","IE00BKVL7J92.USD","BK4501","BK4585","IE00B19Z8W00.USD","LU1791710582.SGD","LU1803068979.SGD","BK4527","LU1366333091.USD","LU1235294995.USD","LU0124676726.USD","LU1551013342.USD","CRMG","BK4551","IE00B19Z9505.USD","LU1814569148.SGD","IE00BQXX3F31.USD","LU0081259029.USD","LU0742534661.SGD","LU0211327993.USD","LU0057025933.USD","LU0354030438.USD","LU1201861249.SGD","LU2458330169.SGD","LU1316542783.SGD","BK4579","LU2286300806.USD","LU0187121727.USD","BK4023","LU1548497426.USD","LU0472753341.HKD","LU0238689110.USD","LU2361045086.USD","IE00BJTD4V19.USD","BK4568","BK4532","BK4538","LU0648000940.SGD","LU0251131958.USD","LU0689626769.HKD","LU2236285917.USD","LU1046421795.USD","LU1923623000.USD","LU0130518102.USD","MRNX","BK4608","BK4534","LU0234570918.USD","IE00BQXX3D17.EUR","LU0198837287.USD","BK4139","LU2461242641.AUD","LU0353189763.USD","LU0251142724.SGD","LU0106261372.USD","LU0889565833.HKD","LU0109392836.USD","LU1791710400.SGD","LU0980610538.SGD","LU0792757196.USD","BK4598","LU0006306889.USD","LU0267386448.USD","LU2247934214.USD","LU0289739343.SGD","LU2087625088.SGD","BK4505","LU0130517989.USD","LU2756315664.SGD","LU0820561818.USD","LU0477156953.USD","LU0820561909.HKD","LU1989764664.SGD","LU1496350171.SGD","LU0048573561.USD","LU1720051017.SGD","BK4533","BK4543","LU0557290698.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146538586","title":"Moderna获欧盟批准上市Mcombriax——全球首款mRNA流感与新冠联合疫苗","url":"https://stock-news.laohu8.com/highlight/detail?id=1146538586","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146538586?lang=zh_cn&edition=full","pubTime":"2026-04-21 21:46","pubTimestamp":1776779188,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna, Inc.宣布，其研发的mRNA联合疫苗Mcombriax已正式获得欧盟委员会的市场营销授权。该疫苗是全球首个采用mRNA技术同时针对流感和COVID-19的联合疫苗，标志着传染病预防领域取得重大突破。\n此次授权为欧盟成员国接种Mcombriax铺平道路，有望简化疫苗接种流程，提升公共卫生防护效率。Moderna的创新疫苗技术平台再次展现其应对复杂病毒威胁的潜力。\n业界分析指出，此次获批将强化Moderna在欧洲疫苗市场的竞争地位，并为其他多价疫苗研发提供重要参考。随着秋冬呼吸道疾病高发季临近，联合疫苗的市场需求预计将持续增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4534","BK4585","BK4501","BK4568","BK4588","BK4551","MRNY","BK4548","MRNA","BK4533","BK4139","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618973837","title":"莫德纳盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618973837","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618973837?lang=zh_cn&edition=full","pubTime":"2026-03-11 23:09","pubTimestamp":1773241765,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日23时09分，莫德纳股票出现波动，股价快速上涨5.04%。截至发稿，该股报57.75美元/股，成交量250.671万股，换手率0.63%，振幅5.35%。莫德纳股票所在的生物技术行业中，整体跌幅为0.22%。其相关个股中，Acurx Pharmaceuticals, Inc.、天演药业、Ocugen, Inc.涨幅较大，Acurx Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals, Inc.、Quince Therapeutics, Inc.较为活跃，换手率分别为1506.86%、1019.35%、62.59%，振幅较大的相关个股有Acurx Pharmaceuticals, Inc.、Kala Bio, Inc.、天演药业，振幅分别为58.62%、50.19%、41.98%。截至 2025 年 8 月，莫德纳有 35 种 mRNA 开发候选药物处于临床研究中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603112309259548dd23&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4501","BK4585","BK4551","BK4534","MRNA","BK4533","BK4532","BK4139","BK4548","MRNY","BK4568","BK4588","MRNX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1199935387","title":"Moderna将于2026年7月8日前向Arbutus/Genevant支付9.5亿美元无条件一次性款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1199935387","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199935387?lang=zh_cn&edition=full","pubTime":"2026-03-05 19:10","pubTimestamp":1772709057,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna, Inc.宣布，其已承诺在2026年7月8日或之前，向合作方Arbutus Biopharma及其子公司Genevant Sciences支付一笔总额高达9.5亿美元的无条件一次性款项。此次支付不附带任何后续条件，标志着双方在相关技术平台合作上的一个重要财务里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4534","BK4585","BK4501","BK4568","BK4588","BK4551","MRNY","BK4548","MRNA","BK4533","BK4139","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144697251","title":"ETF日报｜三倍做多半导体ETF涨近6%；纳指三倍做多ETF涨超4%；加密与半导体产品相对跑赢","url":"https://stock-news.laohu8.com/highlight/detail?id=1144697251","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144697251?lang=zh_cn&edition=full","pubTime":"2026-03-05 09:12","pubTimestamp":1772673133,"startTime":"0","endTime":"0","summary":"美股ETF涨幅Top5$2倍做多GEMI ETF-Leverage Shares$上涨65.93%。该产品两倍做多Galaxy Digital，因公司股价上涨，杠杆效应放大当日涨幅。大盘指数ETF涨幅Top 5$纳指三倍做多ETF$上涨4.49%。$三倍做多MSCI新兴市场ETF-Direxion$上涨2.92%。该产品三倍做多美国小盘股指数，指数当日上行使杠杆产品录得涨幅。该产品三倍做多半导体板块，芯片股集体走强推动杠杆产品上行。该产品配置不动产优先股，相关资产价格上行推动产品上涨。","market":"us","thumbnail":"https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8fd5271ba4885dabd7633b23dfb3304b"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d8aa0ef7daa8f62604f5dfb5c1b0be1b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRLN","SMH","EWP","LU1861217088.USD","BK4588","BK4595","BK4596","UPXI","TQQQ","BKLN","FAS","UGL","CONI","GLXY","BK4585","IREZ","UCO","LU1861558580.USD","SOXL","GLXU","BK4516","XLY","GLGG","BK4535","GEMG","LU2360107671.USD","IREN","SMST","PFFR","BK4600","MSTR","COIN","GEMI","BK4112","IYZ","EDC","USO","PXIU","ASTS","DGP","QLD","BK4551","MRNX","MRNA","BK4550","ICVT","LU1861559042.SGD","NBIZ","ASTN","LU1861220207.SGD","BK4554","NBIS","BK4539","AGQ","CWB","TNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559787","title":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559787","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559787?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:44","pubTimestamp":1772635499,"startTime":"0","endTime":"0","summary":"莫德纳(MRNA)股价上涨14%，创2024年11月以来盘中新高","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603043662053278.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603043662053278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4532","BK4585","BK4139","BK4501","BK4548","BK4551","MRNX","BK4568","BK4534","BK4588","MRNA","MRNY","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616559337","title":"莫德纳盘初股价上涨近14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616559337","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616559337?lang=zh_cn&edition=full","pubTime":"2026-03-04 22:39","pubTimestamp":1772635171,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","BK4139","BK4534","BK4532","BK4501","BK4548","MRNA","BK4588","BK4568","BK4533","BK4551","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132841899","title":"Moderna股价盘前飙升3.7% 公司同意支付高达22.5亿美元和解新冠疫苗专利纠纷","url":"https://stock-news.laohu8.com/highlight/detail?id=1132841899","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132841899?lang=zh_cn&edition=full","pubTime":"2026-03-04 17:10","pubTimestamp":1772615446,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 股价在盘前交易中强势上涨3.7%，此前该公司宣布已达成协议，将支付最高22.5亿美元，以了结与其新冠疫苗相关的专利纠纷。这一重大和解协议消除了笼罩在该公司头顶的一大不确定性，为市场注入了积极情绪。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"8a24082c651a012a7802d63b3e7455d1","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4501","BK4139","MRNY","BK4551","MRNX","BK4588","BK4533","BK4532","BK4534","MRNA","BK4568","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616306583","title":"专利纠纷靴子即将落地 mRNA领军者Moderna(MRNA.US)转身冲向“AI+医疗”浪潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2616306583","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616306583?lang=zh_cn&edition=full","pubTime":"2026-03-04 08:46","pubTimestamp":1772585185,"startTime":"0","endTime":"0","summary":"Moderna将在第三季度支付9.5亿美元，且未来无需再支付任何专利使用费。对于Moderna增长前景而言，如果彻底摆脱专利诉讼，进而无需再支付任何专利使用费，意味着该公司有望将增长重点与研发管道全面转向“AI+医疗”超级大浪潮。Moderna 将成为“AI+医疗”浪潮的下一个爆发标的?Moderna非常有机会把“AI+医疗”真正做成核心估值引擎，尤其是在个体化肿瘤疫苗和平台化 mRNA 药物开发上。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1409749.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","BK4139","BK4534","BK4532","BK4501","BK4548","MRNA","BK4588","BK4568","BK4533","159891","BK4551","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143945821","title":"Moderna预计2026年第一季度将因和解支付计入9.5亿美元费用","url":"https://stock-news.laohu8.com/highlight/detail?id=1143945821","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143945821?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:19","pubTimestamp":1772572752,"startTime":"0","endTime":"0","summary":"生物技术巨头Moderna近日披露，公司预计在2026年第一季度财务报表中确认一笔高达9.5亿美元的费用。这笔巨额支出与一项重大和解协议的支付义务直接相关，反映出公司在法律及商业纠纷解决方面面临的财务影响。该费用的确认将遵循美国通用会计准则（GAAP）的要求，并对当期利润产生显著影响。分析人士指出，此次预提费用虽可能短期压制股价，但彻底解决历史遗留问题有助于Moderna更专注于mRNA技术管线的战略布局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4534","BK4551","BK4585","BK4588","BK4568","BK4501","MRNX","MRNA","MRNY","BK4139","BK4548","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140512903","title":"Moderna最新预测：2026年末现金及现金等价物预计达45-50亿美元区间","url":"https://stock-news.laohu8.com/highlight/detail?id=1140512903","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140512903?lang=zh_cn&edition=full","pubTime":"2026-03-04 05:19","pubTimestamp":1772572752,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 最新更新了其财务展望，宣布将2026年末的现金及现金等价物预期调整至45亿至50亿美元的范围。这一修正后的预测反映了公司对其未来现金流状况的重新评估。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","BK4534","BK4532","BK4501","BK4548","MRNA","BK4588","BK4568","BK4533","BK4551","MRNY","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613730353","title":"Piper Sandler上调莫德纳目标价至69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613730353","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613730353?lang=zh_cn&edition=full","pubTime":"2026-02-23 14:40","pubTimestamp":1771828834,"startTime":"0","endTime":"0","summary":"格隆汇2月23日｜Piper Sandler将莫德纳目标价从63美元上调至69美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223144112a7151e48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260223144112a7151e48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4588","BK4551","MRNX","BK4568","MRNA","BK4501","BK4548","BK4585","BK4533","MRNY","BK4139","BK4534"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0274},{"period":"1month","weight":-0.0848},{"period":"3month","weight":-0.2617},{"period":"6month","weight":0.04},{"period":"ytd","weight":0.04}],"compareEarnings":[{"period":"1week","weight":0.0124},{"period":"1month","weight":0.0493},{"period":"3month","weight":0.0887},{"period":"6month","weight":0.0981},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.1005}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"Defiance Daily Target 2X Long MRNA ETF","nameEN":"Defiance Daily Target 2X Long MRNA ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Defiance Daily Target 2X Long MRNA ETF(MRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Defiance Daily Target 2X Long MRNA ETF,MRNX,Defiance Daily Target 2X Long MRNA ETF股票,Defiance Daily Target 2X Long MRNA ETF股票老虎,Defiance Daily Target 2X Long MRNA ETF股票老虎国际,Defiance Daily Target 2X Long MRNA ETF行情,Defiance Daily Target 2X Long MRNA ETF股票行情,Defiance Daily Target 2X Long MRNA ETF股价,Defiance Daily Target 2X Long MRNA ETF股市,Defiance Daily Target 2X Long MRNA ETF股票价格,Defiance Daily Target 2X Long MRNA ETF股票交易,Defiance Daily Target 2X Long MRNA ETF股票购买,Defiance Daily Target 2X Long MRNA ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Defiance Daily Target 2X Long MRNA ETF(MRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Defiance Daily Target 2X Long MRNA ETF(MRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}